Intravenous iron dextran as a component of anemia management in chronic kidney disease: a report of safety and efficacy.
about
Anemia and iron deficiency in gastrointestinal and liver conditionsIron repletion is associated with reduction in platelet counts in non-dialysis chronic kidney disease patients independent of erythropoiesis-stimulating agent use: a retrospective cohort study.Current evaluation and management of anemia in patients with inflammatory bowel disease.Management of inflammatory bowel disease-related anemia and iron deficiency with specific reference to the role of intravenous iron in current practice.
P2860
Intravenous iron dextran as a component of anemia management in chronic kidney disease: a report of safety and efficacy.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Intravenous iron dextran as a ...... report of safety and efficacy.
@ast
Intravenous iron dextran as a ...... report of safety and efficacy.
@en
type
label
Intravenous iron dextran as a ...... report of safety and efficacy.
@ast
Intravenous iron dextran as a ...... report of safety and efficacy.
@en
prefLabel
Intravenous iron dextran as a ...... report of safety and efficacy.
@ast
Intravenous iron dextran as a ...... report of safety and efficacy.
@en
P2093
P2860
P356
P1476
Intravenous iron dextran as a ...... report of safety and efficacy.
@en
P2093
Alexy Yessayan
Anatole Besarab
Ankur Sandhu
Gerard Zasuwa
Lenar Yessayan
Stan Frinak
P2860
P304
P356
10.1155/2013/703038
P577
2013-03-18T00:00:00Z